Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma

BACKGROUND: Loco-regional therapy for hepatocellular carcinoma (HCC) during the period awaiting liver transplantation (LT) appears to be a logical approach to reduce the risk of tumor progression and dropout in the waitlist. Living donor LT (LDLT) offers a flexible timing for transplantation providi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tsung-Han, Wang, Yu-Chao, Cheng, Chih-Hsien, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Chan, Kun-Ming, Lee, Wei-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943093/
https://www.ncbi.nlm.nih.gov/pubmed/31984121
http://dx.doi.org/10.4240/wjgs.v12.i1.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943093/
https://www.ncbi.nlm.nih.gov/pubmed/31984121
http://dx.doi.org/10.4240/wjgs.v12.i1.17

Ejemplares similares